
|Articles|June 1, 2006
Once-daily alpha-blocker curbs BPH symptoms
Paris-Once-daily administration of a newer alpha-blocker appears to have a positive effect in the treatment of patients suffering from lower urinary tract symptoms and BPH compared with placebo, but comes up short in preventing acute urinary retention occurrence, according to Claus G. Roehrborn, MD, professor and chairman of the department of urology at the University of Texas Southwestern Medical Center, Dallas. Dr. Roehrborn presented the results of a 2-year study at the European Association of Urology annual congress here.
Advertisement
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Veda Giri, MD, on patient-reported outcomes with prostate cancer genetic testing
2
Kristen Scarpato, MD, on combination strategies in BCG-naïve NMIBC
3
Trial to compare 225Ac-PSMA-617 vs 177Lu-PSMA-617 for oligorecurrent prostate cancer
4
Amanda North, MD, recaps SWIU 2026 session on imposter syndrome
5






